• Explore /
  • Poster
  • / Tappas: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (AAS).

Tappas: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (AAS).

Abstract Poster

Authors

Robin Jones

Robin Lewis Jones

Royal Marsden Hospital, The Institute of Cancer Research, London, United Kingdom

Robin Lewis Jones , Steven Attia , Cyrus R. Mehta , Lingyun Liu , Kamalesh Kumar Sankhala , Steven Ian Robinson , Vinod Ravi , Nicolas Penel , Silvia Stacchiotti , William D. Tap , Delia Alvarez , Richard Yocum , Charles P. Theuer , Robert G. Maki

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT02979899

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS11081)

DOI

10.1200/JCO.2017.35.15_suppl.TPS11081

Abstract #

TPS11081

Poster Bd #

403a

Abstract Disclosures

Similar Posters

First Author: Vinod Ravi

First Author: Marie-Cecile Le Deley

First Author: Makoto Endo

First Author: Tomasz M. Beer